This document is a publication of a patent application filed with the USPTO, specifically application number US20260085314A1, titled 'Conjugated Oligonucleotide Compounds, Methods of Making and Uses Thereof.' The application details novel conjugated oligonucleotide compounds suitable for therapeutic use, along with methods for their creation and application in treating various diseases and conditions. The filing date was May 16, 2025.

As this is a patent application, it does not impose direct regulatory obligations or compliance deadlines on entities. However, it signifies potential future intellectual property rights and may inform research and development strategies for pharmaceutical and biotechnology companies. Companies operating in these sectors should be aware of this filing for competitive intelligence and potential licensing opportunities.